Literature DB >> 7206599

Osteogenesis imperfecta: biochemical and clinical evaluation of 13 cases.

T Krieg, E Kirsch, K Matzen, P K Müller.   

Abstract

Skin fibroblasts were cultured from 13 patients with Osteogenesis imperfecta and collagen biosynthesis was investigated in vitro. In those patients characterised by only mild manifestations of the disease, the ratio of collagen types I and III was disturbed. By contrast, fibroblasts obtained from patients with Osteogenesis imperfecta of a more severe type synthesised collagen types I/III in a normal ratio.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7206599     DOI: 10.1007/bf01477288

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  13 in total

1.  Biochemical characteristics and biological significance of the genetically-distinct collagens.

Authors:  E J Miller
Journal:  Mol Cell Biochem       Date:  1976-12-10       Impact factor: 3.396

2.  The marfan's syndrome. In vitro study of collagen metabolism in tissue specimens of the aorta.

Authors:  T Krieg; P K Müller
Journal:  Exp Cell Biol       Date:  1977

3.  Synthesis and degradation of collagen by skin fibroblasts from controls and from patients with osteogenesis imperfecta.

Authors:  B U Steinmann; G R Martin; B I Baum; R G Crystal
Journal:  FEBS Lett       Date:  1979-05-15       Impact factor: 4.124

4.  Altered relation of two collagen types in osteogenesis imperfecta.

Authors:  B Sykes; M J Francis; R Smith
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

5.  Synthesis of collagen by human fibroblasts and their SV40 transformants.

Authors:  T Krieg; M Aumailley; W Dessau; M Wiestner; P Müller
Journal:  Exp Cell Res       Date:  1980-01       Impact factor: 3.905

6.  Isolation and characterization of the peptides derived from soluble human and baboon skin collagen after cyanogen bromide cleavage.

Authors:  E H Epstein; R D Scott; E J Miller; K A Piez
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

7.  Osteogenesis imperfecta congenita: evidence for a generalized molecular disorder of collagen.

Authors:  R L Trelstad; D Rubin; J Gross
Journal:  Lab Invest       Date:  1977-05       Impact factor: 5.662

8.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

9.  Abnormal collagen metabolism in cultured cells in osteogenesis imperfecta.

Authors:  R P Penttinen; J R Lichtenstein; G R Martin; V A McKusick
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

10.  Patients with Ehlers-Danlos syndrome type IV lack type III collagen.

Authors:  F M Pope; G R Martin; J R Lichtenstein; R Penttinen; B Gerson; D W Rowe; V A McKusick
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

View more
  6 in total

1.  Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen.

Authors:  G S Barsh; K E David; P H Byers
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

2.  Influence of cell density on collagen biosynthesis in fibroblast cultures.

Authors:  M Aumailley; T Krieg; G Razaka; P K Müller; H Bricaud
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

3.  Altered glycosaminoglycan production in cultured osteogenesis-imperfecta skin fibroblasts.

Authors:  H Turakainen
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

4.  Heterogeneity of osteogenesis imperfecta type I.

Authors:  C R Paterson; S McAllion; R Miller
Journal:  J Med Genet       Date:  1983-06       Impact factor: 6.318

5.  Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.

Authors:  P H Byers; J R Shapiro; D W Rowe; K E David; K A Holbrook
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

6.  Vertebral bone mineral content in osteogenesis imperfecta.

Authors:  D Kurtz; K Morrish; J Shapiro
Journal:  Calcif Tissue Int       Date:  1985-01       Impact factor: 4.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.